Found 8 matching trials
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer PHASE3 This study is a randomized, double-blind, placebo-controlled, multicenter p...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients PHASE2 This is a multicenter, open-label, exploratory study to evaluate the effica...
Show More Status
Active Not Recruiting
Location
Huadong Hospital Affiliated to Fudan University
Learn More & Join Trial
Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer PHASE2 This is a Phase 2, multicenter, open label, single arm study designed to ev...
Show More Location
Liaoning Cancer Hospital
Learn More & Join Trial
TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer N/A The goal of this observational study is to evaluate the effectiveness and s...
Show More Location
Multiple Locations
Learn More & Join Trial
Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer NA This study aims to observe and evaluate the efficacy and safety of Iparomli...
Show More Location
Multiple Locations
Learn More & Join Trial
QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC PHASE2 The goal of this clinical trial is to evaluate QL1706 plus bevacizumab with...
Show More Location
Multiple Locations
Learn More & Join Trial
QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer N/A This is a clinical research study for women with recurrent or metastatic ce...
Show More Location
Multiple Locations
Learn More & Join Trial
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma PHASE3 The goal of this phase 3 clinical trial is to evaluate whether QL1706 plus ...
Show More Learn More & Join Trial